Application of exosome technique in bone and joint repair backdrop Bone and joint diseases are common health problems worldwide especially among the elderly and those with sports injuries Traditional treatment methods have limited effectiveness and some side effects Based on stem cell and exosome technology Sichuan Xinfi Biology Technology Co Ltd has developed a bone and joint repair program containing stem cell vesicles providing a new treatment option for patients solution The company uses self-developed high-purity exosome extraction technology to isolate exosomes with repair function from stem cell culture supernatant and prepare them into bone and joint repair preparations Through local injection or targeted delivery the preparation directly acts on the damaged bone and joint tissues to promote cell regeneration and tissue repair Case details A 55-year-old osteoarthritis patient with chronic joint pain and limited mobility tried several traditional treatments without significant results After receiving exosomal bone and joint repair treatment from Sichuan Xinbi Science and Technology Co LTD the patient's joint pain was significantly reduced and his mobility gradually recovered After three months of follow-up the patient's joint function basically returned to normal and the quality of life was significantly improved Achievement and significance The success of this case not only validates the effectiveness of exosome technology in bone and joint repair but also provides strong support for the application of stem cell and exosome technology in the field of regenerative medicine Sichuan Xinbi Biological Science and Technology Co Ltd will continue to promote the clinical research and industrialization of this technology to bring good news to more patients Look to the future Sichuan New Science and Technology Co Ltd will continue to be innovation-driven in-depth cultivation of stem cell and exosome technology and expand its application in medical beauty and health fields The company plans to launch more innovative products in the next three years and carry out in-depth cooperation with domestic and foreign scientific research institutions and enterprises to jointly promote the development of the biotechnology industry